Association of Acetaminophen Use During Pregnancy With Behavioral Problems in Childhood: Evidence Against Confounding
- PMID: 27533796
- PMCID: PMC5300094
- DOI: 10.1001/jamapediatrics.2016.1775
Association of Acetaminophen Use During Pregnancy With Behavioral Problems in Childhood: Evidence Against Confounding
Abstract
Importance: Acetaminophen (paracetamol) is used by a large proportion of pregnant women. Research suggests that acetaminophen use in pregnancy is associated with abnormal fetal neurodevelopment. However, it is possible that this association might be confounded by unmeasured behavioral factors linked to acetaminophen use.
Objective: To examine associations between offspring behavioral problems and (1) maternal prenatal acetaminophen use, (2) maternal postnatal acetaminophen use, and (3) partner's acetaminophen use.
Design, setting, and participants: From February 2015 to March 2016, we collected and analyzed data from the Avon Longitudinal Study of Parents and Children (ALSPAC), a prospective birth cohort. We studied 7796 mothers enrolled in ALSPAC between 1991 and 1992 along with their children and partners.
Exposures: Acetaminophen use was assessed by questionnaire completion at 18 and 32 weeks of pregnancy and when the child was 61 months old.
Main outcomes and measures: Maternal reports of behavioral problems using the Strengths and Difficulties Questionnaire (SDQ) when the children were 7 years old. We estimated risk ratios for behavioral problems in children after prenatal, postnatal, and partner's exposure to acetaminophen and mutually adjusted each association.
Results: Maternal prenatal acetaminophen use at 18 (n = 4415; 53%) and 32 weeks of pregnancy (n = 3381; 42%) was associated with higher odds of having conduct problems (risk ratio [RR], 1.42; 95% CI, 1.25-1.62) and hyperactivity symptoms (RR, 1.31; 95% CI, 1.16-1.49), while maternal acetaminophen use at 32 weeks was also associated with higher odds of having emotional symptoms (RR, 1.29; 95% CI, 1.09-1.53) and total difficulties (RR, 1.46; 95% CI, 1.21-1.77). This was not the case for maternal postnatal (n = 6916; 89%) or partner's (n = 3454; 84%) acetaminophen use. We found the associations between maternal prenatal acetaminophen use and all the SDQ domains unchanged even after adjusting for maternal postnatal or partner's acetaminophen use.
Conclusions and relevance: Children exposed to acetaminophen prenatally are at increased risk of multiple behavioral difficulties, and the associations do not appear to be explained by unmeasured behavioral or social factors linked to acetaminophen use insofar as they are not observed for postnatal or partner's acetaminophen use. Although these results could have implications for public health advice, further studies are required to replicate the findings and to understand mechanisms.
Conflict of interest statement
Disclosures: None reported.
Comment in
-
Acetaminophen in Pregnancy and Adverse Childhood Neurodevelopment.JAMA Pediatr. 2017 Apr 1;171(4):394-395. doi: 10.1001/jamapediatrics.2016.5034. JAMA Pediatr. 2017. PMID: 28192543 No abstract available.
-
Acetaminophen in Pregnancy and Adverse Childhood Neurodevelopment.JAMA Pediatr. 2017 Apr 1;171(4):395. doi: 10.1001/jamapediatrics.2016.5037. JAMA Pediatr. 2017. PMID: 28192546 No abstract available.
-
Acetaminophen in Pregnancy and Adverse Childhood Neurodevelopment.JAMA Pediatr. 2017 Apr 1;171(4):396. doi: 10.1001/jamapediatrics.2016.5049. JAMA Pediatr. 2017. PMID: 28192547 No abstract available.
-
Acetaminophen in Pregnancy and Adverse Childhood Neurodevelopment.JAMA Pediatr. 2017 Apr 1;171(4):395-396. doi: 10.1001/jamapediatrics.2016.5046. JAMA Pediatr. 2017. PMID: 28192549 No abstract available.
-
Acetaminophen in Pregnancy and Adverse Childhood Neurodevelopment-Reply.JAMA Pediatr. 2017 Apr 1;171(4):396-397. doi: 10.1001/jamapediatrics.2016.5040. JAMA Pediatr. 2017. PMID: 28192550 No abstract available.
Similar articles
-
Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders.JAMA Pediatr. 2014 Apr;168(4):313-20. doi: 10.1001/jamapediatrics.2013.4914. JAMA Pediatr. 2014. PMID: 24566677
-
Behavioral Problems at Age 11 Years After Prenatal and Postnatal Exposure to Acetaminophen: Parent-Reported and Self-Reported Outcomes.Am J Epidemiol. 2021 Jun 1;190(6):1009-1020. doi: 10.1093/aje/kwaa257. Am J Epidemiol. 2021. PMID: 33230558 Free PMC article.
-
Prenatal paracetamol exposure and asthma: further evidence against confounding.Int J Epidemiol. 2010 Jun;39(3):790-4. doi: 10.1093/ije/dyq049. Epub 2010 Mar 30. Int J Epidemiol. 2010. PMID: 20356852
-
Fetal programming of mental health by acetaminophen? Response to the SMFM statement: prenatal acetaminophen use and ADHD.Expert Opin Drug Saf. 2017 Dec;16(12):1395-1398. doi: 10.1080/14740338.2017.1384812. Epub 2017 Oct 3. Expert Opin Drug Saf. 2017. PMID: 28942678 Review.
-
New problems arising from old drugs: second-generation effects of acetaminophen.Expert Rev Clin Pharmacol. 2014 Sep;7(5):655-62. doi: 10.1586/17512433.2014.944502. Epub 2014 Jul 30. Expert Rev Clin Pharmacol. 2014. PMID: 25075430 Review.
Cited by
-
Inhibitory Effect of Acetaminophen on Ocular Pigmentation and its Relationship with Thyroxine in Zebrafish Embryos.Bull Environ Contam Toxicol. 2024 Feb 14;112(2):39. doi: 10.1007/s00128-024-03867-0. Bull Environ Contam Toxicol. 2024. PMID: 38353786
-
The Dangers of Acetaminophen for Neurodevelopment Outweigh Scant Evidence for Long-Term Benefits.Children (Basel). 2023 Dec 29;11(1):44. doi: 10.3390/children11010044. Children (Basel). 2023. PMID: 38255358 Free PMC article. Review.
-
The relationship of prenatal acetaminophen exposure and attention-related behavior in early childhood.Neurotoxicol Teratol. 2024 Jan-Feb;101:107319. doi: 10.1016/j.ntt.2024.107319. Epub 2024 Jan 8. Neurotoxicol Teratol. 2024. PMID: 38199313 Free PMC article.
-
Examining the relationship of acetaminophen use during pregnancy with early language development in children.Pediatr Res. 2024 Jun;95(7):1883-1896. doi: 10.1038/s41390-023-02924-4. Epub 2023 Dec 11. Pediatr Res. 2024. PMID: 38081897 Free PMC article.
-
Postnatal acetaminophen exposure and neurodevelopmental outcomes at 18-21 months corrected gestational age in preterm infants <29 weeks gestation: a retrospective cohort study.Pediatr Res. 2024 Jul;96(2):388-394. doi: 10.1038/s41390-023-02901-x. Epub 2023 Dec 7. Pediatr Res. 2024. PMID: 38057580
References
-
- Werler MM, Mitchell AA, Hernandez-Diaz S, Honein MA. Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol. 2005;193(3, pt 1):771–777. - PubMed
-
- Viberg H, Eriksson P, Gordh T, Fredriksson A. Paracetamol (acetaminophen) administration during neonatal brain development affects cognitive function and alters its analgesic and anxiolytic response in adult male mice. Toxicol Sci. 2014;138(1):139–147. - PubMed
-
- Patel J, Landers K, Li H, Mortimer RH, Richard K. Thyroid hormones and fetal neurological development. J Endocrinol. 2011;209(1):1–8. - PubMed
-
- Jensen MS, Rebordosa C, Thulstrup AM, et al. Maternal use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy and risk of cryptorchidism. Epidemiology. 2010;21(6):779–785. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
